glp-1 drug news today 2025 access and 2026 health benefits: What consumers expect New survey data shows 59% of Americans support the Trump administration's plan to broaden access to GLP-1 drugs for weight-loss at discounted Patients taking an experimental oral
Description
Archives of Physiology and Biochemistry
Properties of these agents are summarized in Table 1
Other Users Companies Mentioned: Novo Nordisk A/S
This systematic review evaluates the literature on the relationship between GLP-1 RA use and increased regurgitation and aspiration events to contextualize the existing, consensus-based guidelines put forth by the ASA in light of limited comparative evidence
"Treatment of Infertility in Women with Polycystic Ovary Syndrome: Approach to Clinical Practice." Clinics (So Paulo) , vol
